NB

Neeraj Bhatia

Active Director Director DIN 01011760
DIN 01011760 First appointment Jun 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Jun 2005
Shareholding value •••• Premium profile

About Neeraj Bhatia

Data last updated:

Neeraj Bhatia is a Director at Three B Healthcare Limited (since 2005), Director at Transcon Hi-Tech Equipments Private Limited (since 2012) and Director at Blueberry Biotech Private Limited (since 2013). The companies operate in Pharma, Packaging and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹83.95 Cr; the largest is Three B Healthcare Limited at ₹68.95 Cr (FY 2024). Earlier, Neeraj Bhatia was a Director at Mukundvallabh Developers Private Limited (2024–2025) and Director at American Vitamins India Private Limited (2019–2024) and 2 more.

DIN 01011760
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 2005
Oldest Company Age 21 yrs
Largest company Three B Healthcare Limited · ₹68.95 Cr (FY 2024)
Combined revenue ₹83.95 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Three B Healthcare Limited U24232DL2005PLC137553
Director14 Jun 20052005₹68.95 Cr (FY 2024)Active
Director02 Nov 20122009₹15.00 Cr (FY 2024)Active
Blueberry Biotech Private Limited U24100DL2013PTC249212
Director07 Mar 20132013Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jan 20242024Active
Director30 Aug 20192019₹7.96 Cr (FY 2024)Active
Pontika Aerotech Limited U74999HP2017PLC006726
Director04 Sep 20172017₹319 Cr (FY 2025)Active
Voler Pharma Private Limited U52390TG2014PTC096586
Director24 Apr 20152014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Neeraj Bhatia

Directorship timeline

Open interactive timeline →
Blueberry Biotech Private Limited
Three B Healthcare Limited
Transcon Hi-Tech Equipments Private Limited
Mukundvallabh Developers Private Limited
Premium access

Shareholding and investment profile for Neeraj Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Bhatia

Neeraj Bhatia currently holds 3 directorships: Three B Healthcare Limited (Director, since 14 Jun 2005, revenue ₹68.95 Cr (FY 2024)); Transcon Hi-Tech Equipments Private Limited (Director, since 02 Nov 2012, revenue ₹15.00 Cr (FY 2024)); Blueberry Biotech Private Limited (Director, since 07 Mar 2013).

Neeraj Bhatia was first appointed on 14 Jun 2005 as Director at Three B Healthcare Limited. The most recent appointment on record is 10 Jan 2024 at Mukundvallabh Developers Private Limited.

The 2 current companies of Neeraj Bhatia that report revenue have a combined latest revenue of ₹83.95 Cr: Three B Healthcare Limited ₹68.95 Cr (FY 2024); Transcon Hi-Tech Equipments Private Limited ₹15.00 Cr (FY 2024).

Neeraj Bhatia held 4 earlier board appointments: Mukundvallabh Developers Private Limited (Director, 10 Jan 2024 to 18 Jul 2025); American Vitamins India Private Limited (Director, 30 Aug 2019 to 12 Aug 2024); Pontika Aerotech Limited (Director, 04 Sep 2017 to 12 Sep 2024); Voler Pharma Private Limited (Director, 24 Apr 2015 to 01 May 2017).

The current boards of Neeraj Bhatia's companies include Lalit Bhatia (Three B Healthcare Limited), Nipun Batra (Three B Healthcare Limited), Rajendra Rajpoot Singh (Three B Healthcare Limited), Naveen Bhatia (Blueberry Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available